Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;26(11):2678-2684.
doi: 10.3201/eid2611.181418.

Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013

Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013

Josep Alvarez et al. Emerg Infect Dis. 2020 Nov.

Abstract

We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within <7 days, 8-14 days, 15-21 days, and >21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within <21 days after the primary patient's symptom onset, the treatment was 43.9% effective. Chemoprophylaxis started >14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within <14 days after primary patient's symptom onset.

Keywords: Bordetella pertussis; Spain; antimicrobials; azithromycin; bacteria; chemoprophylaxis; effectiveness; household contacts; pertussis; prevention; respiratory infections.

PubMed Disclaimer

Figures

Figure
Figure
Flowchart of study of effectiveness of chemoprophylaxis in preventing pertussis transmission among household contacts of primary index patients, Catalonia and Navarre, Spain, 2012–2013. *Pooled data.

References

    1. World Health Organization Strategic Advisory Group of Experts Pertussis Working Group. Background paper [cited 2020 Feb 9]. http://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_bac...
    1. Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, et al. Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J. 2015;34:e222–32. 10.1097/INF.0000000000000795 - DOI - PubMed
    1. Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, et al. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine. 2011;29:4244–8. 10.1016/j.vaccine.2011.03.065 - DOI - PubMed
    1. Sala-Farré MR, Arias-Varela C, Recasens-Recasens A, Simó-Sanahuja M, Muñoz-Almagro C, Pérez-Jové J. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine. Enferm Infecc Microbiol Clin. 2015;33:27–31. 10.1016/j.eimc.2013.09.013 - DOI - PubMed
    1. Sizaire V, Garrido-Estepa M, Masa-Calles J, Martinez de Aragon MV. Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain. Euro Surveill. 2014;19:20875. 10.2807/1560-7917.ES2014.19.32.20875 - DOI - PubMed

Publication types